Stream Biomedical was founded to address unmet therapeutic needs for individuals suffering as a result of neurologic trauma and/or degeneration. The goal is to save brain and associated function from potentially debilitating outcomes... to best preserve what makes us who we are.
Stream Biomedical is commercializing a therapeutic protein which has been shown to be significantly neuroprotective and neuroreparative, resulting in dramatic functional improvement when administered after neurologic insult. The initial target therapeutic application is for the treatment of acute stroke. Later targets include traumatic brain injury (TBI) and Alzheimer's/dementia.
The Unmet Need
in the United States of America